drugset / Trial / NCT01424332

To Evaluate Whether Acetyl Salicylic Acid (Aspirin) and Darexaban (YM150) Interact in Their Effects

NCT01424332

Phase 1 Completed 24 enrolled Astellas Pharma Inc
RandomizedCrossoverOpen-label

Summary

The primary objective of this study is to evaluate whether ASA and darexaban which have different effects on blood coagulation influence each other in their effects. Also it will be investigated whether the blood levels of either drug are influenced by the presence of the other drug. In addition, the safety and tolerability of each drug and the combination of the drugs will be investigated.

Timeline

Start
2007-12
Primary completion
2008-03
Completion
2008-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Aspirin Small molecule Oral
Subject darexaban Small molecule Oral

Indications

No indication recorded.